Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.66 |
| ▸ | CA2 | P00918 | 4/20 | 0.66 |
| ▸ | CA9 | Q16790 | 3/20 | 0.66 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | MMP9 | P14780 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL28745712 | 0.98 | CA1 (0.63) | CA1CA2CA9POLBCA12 | |
| SCHEMBL3258334 | 0.89 | CA2 (0.50) | CA1CA2CA9CA12ALDH1A1 | |
| SCHEMBL6041848 | 0.89 | CA1 (0.53) | CA1CA2CA9POLBCA12 | |
| SCHEMBL1938089 | 0.89 | CA1 (0.53) | CA1CA2CA9 | |
| SCHEMBL491533 | 0.88 | POLB (0.53) | CA1CA2CA9POLBALDH1A1 | |
| SCHEMBL2658522 | 0.86 | KDM4E (0.56) | CA1CA2CA9POLBALDH1A1 | |
| SCHEMBL19169156 | 0.86 | CA1 (0.50) | CA1CA2CA9POLBCA12 | |
| SCHEMBL24041893 | 0.85 | FFAR1 (0.57) | CA1CA2CA9CA12CA7 | |
| SCHEMBL5691423 | 0.85 | AR (0.56) | CA1CA2CA9CA12CA7 | |
| SCHEMBL10390508 | 0.85 | KDM4E (0.54) | CA1CA2CA9POLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113480455-B | Preparation method of mirabegron related substance and intermediate thereof | 浙江恒康药业股份有限公司 | 2023-03-24 | — | — | CN | claimed |
| CN-111505163-B | Method for detecting phenethyl methane sulfonate substances | 上海博悦生物科技有限公司 | 2021-02-12 | — | — | CN | claimed |
| CN-111505163-A | Method for detecting phenethyl methane sulfonate substances | 上海博悦生物科技有限公司 | 2020-08-07 | — | — | CN | claimed |
| CN-116194439-B | SOCE inhibitors and therapeutic uses thereof | 国家医疗保健研究所 | 2025-04-08 | — | — | CN | disclosed |
| CN-112218853-B | Process for the stereoselective preparation of chiral 2- [ (hetero) aralkylthio ] pyrimidines and products obtainable therefrom | 坎塞拉有限公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-111936498-B | N- (3- (7H-pyrrolo [2,3-d ] pyrimidin-4-yl) phenyl) benzamide derivatives | 诺华股份有限公司 | 2024-04-16 | — | — | CN | disclosed |
| US-20240116876-A1 | SOCE Inhibitors and Therapeutic Uses Thereof | Institut National de la Santé et de la Recherche Médicale (FR) | 2024-04-11 | — | — | US | disclosed |
| CN-117186108-A | Bruton's tyrosine kinase degradation agent | 诺华股份有限公司 | 2023-12-08 | — | — | CN | disclosed |
| CN-111936501-B | Bruton's tyrosine kinase degradation agent | 诺华股份有限公司 | 2023-09-22 | — | — | CN | disclosed |
| CN-116676101-A | Sulfur-containing low-temperature molten salt and application thereof in removal of aromatic sulfides in fuel oil | 安阳工学院 | 2023-09-01 | — | — | CN | disclosed |
| CN-116194439-A | SOCE inhibitors and therapeutic uses thereof | 国家医疗保健研究所 | 2023-05-30 | — | — | CN | disclosed |
| EP-0161904-B1 | TETRAHYDROFURANYL AND TETRAHYDROTHIENYL SUBSTITUTED ETHERS | E.R. Squibb & Sons, Inc. (US) | 1989-10-18 | — | — | EP | disclosed |
| EP-0163416-B1 | PHENOL DERIVATIVES | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1989-05-31 | — | — | EP | disclosed |
| US-4751240-A | ANTIFERTILITY AGENTS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1988-06-14 | — | — | US | disclosed |
| WO-1986004893-A1 | PROCESS FOR THE PREPARATION OF ALKYL FLUORIDES | ZAMBON S.P.A. (IT) | 1986-08-28 | — | — | WO | disclosed |
| EP-0163416-A2 | Phenol derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1985-12-04 | — | — | EP | disclosed |
| EP-0161904-A2 | Tetrahydrofuranyl and tetrahydrothienyl substituted ethers | E.R. Squibb & Sons, Inc. (US) | 1985-11-21 | — | — | EP | disclosed |
| US-4542151-A | CARDIOVASCULAR, BRONCHODILATION, ANALGESICS, ANTIINFLAMMATORY | E. R. SQUIBB & SONS, INC. (US) | 1985-09-17 | — | — | US | disclosed |
| US-4521539-A | ANALGESICS, CARDIONVASCULAR AND ANTIINFLAMMATORY AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1985-06-04 | — | — | US | disclosed |
| US-4150135-A | ANALGESICS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1979-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240116876-A1 | SOCE Inhibitors and Therapeutic Uses Thereof | STIM1, ORAI1, STIM2 | CA1 1138/4885CA2 38/4885CA9 1100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.